Literature DB >> 27861830

Hemicrania Continua: Beneficial Effect of Non-Invasive Vagus Nerve Stimulation in a Patient With a Contraindication for Indomethacin.

Ozan Eren1, Andreas Straube1, Florian Schöberl1, Christoph Schankin1,2.   

Abstract

Hemicrania continua (HC) is a primary chronic headache disorder, characterized by a continuous and strictly unilateral headache, with possible cranial autonomic symptoms during episodes of pain exacerbation. The unilateral headache generally responds well to indomethacin; however, continuous indomethacin intake is often not tolerated due to severe adverse effects, like hypertension, gastrointestinal discomfort (especially if combined with aspirin), slightly increased risk of vascular events, and bronchial spasms. Therefore, alternative treatment options are desperately needed. Non-invasive vagus nerve stimulation (nVNS) has been shown to be effective in patients with cluster headache, another trigeminal autonomic cephalalgia (TAC), with cranial parasympathetic autonomic activation during the attacks.
© 2016 American Headache Society.

Entities:  

Keywords:  gammaCore; hemicrania continua; indomethacin contraindication; neuromodulation; non-invasive vagus nerve stimulation; treatment

Mesh:

Substances:

Year:  2016        PMID: 27861830     DOI: 10.1111/head.12977

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  6 in total

1.  Noninvasive Vagus Nerve Stimulation for Treatment of Indomethacin-Sensitive Headaches.

Authors:  Amy R Tso; Juana Marin; Peter J Goadsby
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

Review 2.  Hemicrania Continua: a Clinical Perspective on Diagnosis and Management.

Authors:  Amit Mehta; Priyanka Chilakamarri; Adeel Zubair; Deena E Kuruvilla
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-17       Impact factor: 5.081

Review 3.  Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.

Authors:  Carlo Baraldi; Lanfranco Pellesi; Simona Guerzoni; Maria Michela Cainazzo; Luigi Alberto Pini
Journal:  J Headache Pain       Date:  2017-07-20       Impact factor: 7.277

Review 4.  Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias.

Authors:  Diana Y Wei; Rigmor H Jensen
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 5.  Hemicrania continua: clinical review, diagnosis and management.

Authors:  Sanjay Prakash; Payal Patel
Journal:  J Pain Res       Date:  2017-06-29       Impact factor: 3.133

Review 6.  Hemicrania Continua.

Authors:  Sanjay Prakash; Bansi Adroja
Journal:  Ann Indian Acad Neurol       Date:  2018-04       Impact factor: 1.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.